12-6333794-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_001065.4(TNFRSF1A):c.265T>C(p.Phe89Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F89S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001065.4 missense
Scores
Clinical Significance
Conservation
Publications
- TNF receptor 1-associated periodic fever syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine, Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001065.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFRSF1A | NM_001065.4 | MANE Select | c.265T>C | p.Phe89Leu | missense | Exon 3 of 10 | NP_001056.1 | ||
| TNFRSF1A | NR_144351.2 | n.527T>C | non_coding_transcript_exon | Exon 3 of 9 | |||||
| TNFRSF1A | NM_001346091.2 | c.-60T>C | 5_prime_UTR | Exon 2 of 9 | NP_001333020.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFRSF1A | ENST00000162749.7 | TSL:1 MANE Select | c.265T>C | p.Phe89Leu | missense | Exon 3 of 10 | ENSP00000162749.2 | ||
| TNFRSF1A | ENST00000366159.9 | TSL:1 | n.299T>C | non_coding_transcript_exon | Exon 3 of 10 | ||||
| TNFRSF1A | ENST00000534885.5 | TSL:1 | n.111T>C | non_coding_transcript_exon | Exon 2 of 9 | ENSP00000441803.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
TNF receptor-associated periodic fever syndrome (TRAPS) Uncertain:1Other:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects TNFRSF1A function (PMID: 21420073). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TNFRSF1A protein function. ClinVar contains an entry for this variant (Variation ID: 97676). This missense change has been observed in individuals with clinical features of TNFRSF1A-related conditions (PMID: 21420073, 23965844; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 89 of the TNFRSF1A protein (p.Phe89Leu).
not provided Pathogenic:1
The F89L variant has been published previously in association with TRAPS (Lachmann et al., 2014). Additionally, other publications have reported this variant as F60L, arising from both a c.264 C>G and a c.267 A>G nucleotide change (Aganna et al., 2003; Dinc et al., 2005). While these papers may be reporting the same F60L variant caused by separate nucleotide changes, they did not include information necessary for us to determine the cause of these nomenclature discrepancies. The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. F89L is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved; however, in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown that F89L increases TNF-stimulated c-Rel activity (Nedjai et al., 2011). Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at